← Leaderboards
Alan F Schatzberg
Stanford University
$23,769,347
Attributed
$27,167,774
Total exposure
20
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,102,577 · 21
By mechanism
R01$11,232,215 · 3
T32$8,971,093 · 1
R25$2,516,992 · 1
R24$2,412,553 · 2
P30$1,565,800 · 1
U01$1,462,348 · 1
Top collaborators
- Erika E Forbes10 shared
- Rachel Manber6 shared
- David J Kupfer4 shared
- Carolyn I Rodriguez3 shared
- Faith M. Gunning1 shared
- Conor M Liston1 shared
Most similar at Stanford University
Same institution · by research overlap
- David Spiegel$11,331,774
- Sylvia Katina Plevritis$44,733,712
- Brent H Solvason$529,467
- David Matthew Maahs$18,119,674
- Linda C Giudice$28,525,430
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectResearch TrainingProgramsMental DisordersResearch PersonnelCortisolMifepristoneMajor DepressionHuman Therapy EvaluationBaseHormone Regulation /Control MechanismBiobehaviorMental Disorder ChemotherapyWomanTraining ProgramsResponseBehavioral SciencesAppointmentDopamineSaimiriFacultyCareer DevelopmentMember
Grant awards (101)
A Biobehavioral Research Training Grant$384,042
T32 · FY2025 · MH · contact PI
The Career Development Institute for Psychiatry$214,336
R25 · FY2025 · MH
A Biobehavioral research Training Program$432,665
T32 · FY2024 · MH · contact PI
The Career Development Institute for Psychiatry$214,607
R25 · FY2024 · MH
A Biobehavioral research Training Program$382,520
T32 · FY2023 · MH · contact PI
The Career Development Institute for Psychiatry$1
R25 · FY2023 · MH
Efficacy of biomarker-guided rTMS for treatment resistant depression$1,307,136
R01 · FY2022 · MH
A Biobehavioral research Training Program$295,698
T32 · FY2022 · MH · contact PI
The Career Development Institute for Psychiatry$218,041
R25 · FY2022 · MH
A Biobehavioral research Training Program$272,733
T32 · FY2021 · MH · contact PI
A Biobehavioral research Training Program$399,062
T32 · FY2020 · MH · contact PI
Research Career Development Institute for Psychiatry$208,242
R25 · FY2020 · MH
Research Career Development Institute for Psychiatry$202,205
R25 · FY2019 · MH
A Biobehavioral Research Training Program$326,834
T32 · FY2018 · MH · contact PI
Research Career Development Institute for Psychiatry$211,370
R25 · FY2018 · MH
A Biobehavioral Research Training Program$410,921
T32 · FY2017 · MH · contact PI
Research Career Development Institute for Psychiatry$202,796
R25 · FY2017 · MH
A Biobehavioral Research Training Program$9,494
T32 · FY2017 · MH · contact PI
A Biobehavioral Research Training Program$415,561
T32 · FY2016 · MH · contact PI
Research Career Development Institute for Psychiatry$213,370
R25 · FY2016 · MH
A Biobehavioral Research Training Program$370,592
T32 · FY2015 · MH · contact PI
Research Career Development Institute for Psychiatry$160,966
R25 · FY2015 · MH
A Biobehavioral Research Training Program$300,607
T32 · FY2014 · MH · contact PI
Research Career Development Institute for Psychiatry$172,919
R25 · FY2014 · MH
A Biobehavioral Research Training Program$397,152
T32 · FY2013 · MH · contact PI
Research Career Development Institute for Psychiatry$155,115
R25 · FY2013 · MH
A Biobehavioral Research Training Program$290,813
T32 · FY2012 · MH · contact PI
Research Career Development Institute for Psychiatry$174,291
R25 · FY2012 · MH
A Biobehavioral Research Training Program$335,003
T32 · FY2011 · MH · contact PI
Research Career Development Institute for Psychiatry$168,733
R25 · FY2011 · MH
Stanford Mood Disorders Center: Enhancing Core Clinical Research Resources$800,000
P30 · FY2010 · MH · contact PI
Model of Hypercortisolism for Major Depression$610,801
R01 · FY2010 · MH · contact PI
A Biobehavioral Research Training Program$384,789
T32 · FY2010 · MH · contact PI
Stanford Mood Disorders Center: Enhancing Core Clinical Research Resources$765,800
P30 · FY2009 · MH · contact PI
Model of Hypercortisolism for Major Depression$611,959
R01 · FY2009 · MH · contact PI
HPA Axis/Dopamine Interactions in Psychotic Depression$578,652
R01 · FY2009 · MH · contact PI
A Biobehavioral Research Training Program$227,856
T32 · FY2009 · MH · contact PI
Model of Hypercortisolism for Major Depression$452,028
R01 · FY2008 · MH · contact PI
A Biobehavioral Research Training Program$431,150
T32 · FY2008 · MH · contact PI
REVAMP-Follow-Up Study$59,528
U01 · FY2008 · MH · contact PI
HPA Axis/Dopamine Interactions in Psychotic Depression$594,571
R01 · FY2007 · MH · contact PI
Model of Hypercortisolism for Major Depression$438,352
R01 · FY2007 · MH · contact PI
A Biobehavioral Research Training Program$364,594
T32 · FY2007 · MH · contact PI
REVAMP-Follow-Up Study$63,841
U01 · FY2007 · MH · contact PI
HPA AXIS/SLEEP/GCRC$49,152
M01 · FY2007 · RR · contact PI
Model of Hypercortisolism for Major Depression$622,957
R01 · FY2006 · MH · contact PI
HPA Axis/Dopamine Interactions in Psychotic Depression$602,515
R01 · FY2006 · MH · contact PI
A Biobehavioral Research Training Program$369,620
T32 · FY2006 · MH · contact PI
REVAMP-Follow-Up Study$62,194
U01 · FY2006 · MH · contact PI
HPA AXIS/SLEEP/GCRC$32,468
M01 · FY2006 · RR · contact PI
OPEN-LABEL TREATMENT OF SCHIZOFFECTIVE DISORDER USING MIFEPRISTONE$18,236
M01 · FY2006 · RR · contact PI
HPA Axis/Dopamine Interactions in Psychotic Depression$623,795
R01 · FY2005 · MH
A Biobehavioral Research Training Program$406,651
T32 · FY2005 · MH
CBASP Augmentation for Treatment of Chronic Depression$318,579
U01 · FY2005 · MH
HPA AXIS/SLEEP/NORMALS$11,694
M01 · FY2005 · RR
HPA AXIS/SLEEP/GCRC$10,357
M01 · FY2005 · RR
MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONS$518,777
R01 · FY2004 · MH
CBASP Augmentation for Treatment of Chronic Depression$388,894
U01 · FY2004 · MH
A Biobehavioral Research Training Program$360,709
T32 · FY2004 · MH
An Open-Label Study of the Treatment of Schizoaffective Disorder and Psychotic$8,001
M01 · FY2004 · RR
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$643,214
R01 · FY2003 · MH
MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONS$545,189
R01 · FY2003 · MH
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD$485,433
R24 · FY2003 · MH
A BIOBEHAVIORAL RESEARCH TRAINING PROGRAM$424,805
T32 · FY2003 · MH
CBASP Augmentation for Treatment of Chronic Depression$300,560
U01 · FY2003 · MH
MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONS$556,029
R01 · FY2002 · MH
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$505,130
R01 · FY2002 · MH
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD$487,509
R24 · FY2002 · MH
A BIOBEHAVIORAL RESEARCH TRAINING PROGRAM$347,103
T32 · FY2002 · MH
CBASP Augmentation for Treatment of Chronic Depression$268,752
U01 · FY2002 · MH
Core--Recruitment$159,250
R24 · FY2002 · MH
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$92,667
R01 · FY2002 · MH
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$497,214
R01 · FY2001 · MH
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD$484,110
R24 · FY2001 · MH
MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONS$458,443
R01 · FY2001 · MH
A BIOBEHAVIORAL RESEARCH TRAINING PROGRAM$327,562
T32 · FY2001 · MH
Core--Recruitment$159,250
R24 · FY2001 · MH
COGNITIVE CHANGES IN PSYCHOTIC DEPRESSION$134,676
M01 · FY2001 · RR
HPA AXIS/DOPAMINE INTERACTION IN PSYCHOTIC DEPRESSION$134,676
M01 · FY2001 · RR
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$134,676
M01 · FY2001 · RR
OPEN LABEL TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$134,676
M01 · FY2001 · RR
HYPOTHALAMIC PITUITARY ACTIVITY &COGNITIVE FUNCTIONS FOR HIV PATIENT$134,676
M01 · FY2001 · RR
RAPID REVERSAL OF PSYCHOTIC MAJOR DEPRESSION USING RU 486$134,676
M01 · FY2001 · RR
COGNITIVE CHANGES IN PSYCHOTIC DEPRESSION$0
M01 · FY2001 · RR
HPA AXIS/DOPAMINE INTERACTION IN PSYCHOTIC DEPRESSION$0
M01 · FY2001 · RR
HYPOTHALAMIC PITUITARY ACTIVITY &COGNITIVE FUNCTIONS FOR HIV PATIENT$0
M01 · FY2001 · RR
RAPID REVERSAL OF PSYCHOTIC MAJOR DEPRESSION USING RU 486$0
M01 · FY2001 · RR
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$0
M01 · FY2001 · RR
OPEN LABEL TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$0
M01 · FY2001 · RR
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$525,718
R01 · FY2000 · MH
COGENT TO SUPPORT CLINICAL RESEARCH AT STANFORD$477,751
R24 · FY2000 · MH
MODEL OF HYPERCORTISOLISM FOR MAJOR DEPRESSIONS$447,068
R01 · FY2000 · MH
A BIOBEHAVIORAL RESEARCH TRAINING PROGRAM$302,557
T32 · FY2000 · MH
Core--Recruitment$159,250
R24 · FY2000 · MH
COGNITIVE CHANGES IN PSYCHOTIC DEPRESSION$602
M01 · FY2000 · RR
HPA AXIS/DOPAMINE INTERACTIONS IN PSYCHOTIC DEPRESSION$602
M01 · FY2000 · RR
TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$602
M01 · FY2000 · RR
OPEN LABEL TREATMENT OF SCHIZOAFFECTIVE DISORDER USING MIFEPRISTONE$602
M01 · FY2000 · RR
HYPOTHALAMIC PITUITARY ACTIVITY &COGNITIVE FUNCTIONS FOR HIV PATIENT$602
M01 · FY2000 · RR
RAPID REVERSAL OF PSYCHOTIC MAJOR DEPRESSION USING RU 486$602
M01 · FY2000 · RR
HPA AXIS/DOPAMINE INTERACTION IN PSYCHOTIC DEPRESSION$0
M01 · FY2000 · RR